Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Withers

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Blood|February 18, 2014
CLEC-2 is required for development and maintenance of lymph nodesCécile Bénézech, Saba Nayar, Brenda A Finney, et al.
Cell Reports|June 28, 2018
Anti-microbial Functions of Group 3 Innate Lymphoid Cells in Gut-Associated Lymphoid Tissues Are Regulated by G-Protein-Coupled Receptor 183Coco Chu, Saya Moriyama, Zhi Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 25, 2017
Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor ImmunityMaher G Nawaf, Maria H Ulvmar, David R Withers, et al.
Nature Communications|January 10, 2015
CCR7-dependent trafficking of RORγ⁺ ILCs creates a unique microenvironment within mucosal draining lymph nodesEmma C Mackley, Stephanie Houston, Clare L Marriott, et al.
Nature Communications|March 30, 2016
Corrigendum: CCR7-dependent trafficking of RORγ(+) ILCs creates a unique microenvironment within mucosal draining lymph nodesEmma C Mackley, Stephanie Houston, Clare L Marriott, et al.
Journal of Hepatology|July 17, 2012
CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liverYe Htun Oo, Vanessa Banz, Dean Kavanagh, et al.
Cell|August 18, 2021
Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancerJeremy Goc, Mengze Lv, Nicholas J Bessman, et al.
Nature Medicine|February 16, 2016
Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cellsDavid R Withers, Matthew R Hepworth, Xinxin Wang, et al.
Nature Immunology|September 24, 2021
T-bet and RORα control lymph node formation by regulating embryonic innate lymphoid cell differentiationChristina Stehle, Timo Rückert, Rémi Fiancette, et al.
Mucosal Immunology|January 8, 2021
Intestinal-derived ILCs migrating in lymph increase IFNγ production in response to Salmonella Typhimurium infectionVerena Kästele, Johannes Mayer, Edward S Lee, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Blood|February 18, 2014
CLEC-2 is required for development and maintenance of lymph nodesCécile Bénézech, Saba Nayar, Brenda A Finney, et al.
Cell Reports|June 28, 2018
Anti-microbial Functions of Group 3 Innate Lymphoid Cells in Gut-Associated Lymphoid Tissues Are Regulated by G-Protein-Coupled Receptor 183Coco Chu, Saya Moriyama, Zhi Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 25, 2017
Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor ImmunityMaher G Nawaf, Maria H Ulvmar, David R Withers, et al.
Nature Communications|January 10, 2015
CCR7-dependent trafficking of RORγ⁺ ILCs creates a unique microenvironment within mucosal draining lymph nodesEmma C Mackley, Stephanie Houston, Clare L Marriott, et al.
Nature Communications|March 30, 2016
Corrigendum: CCR7-dependent trafficking of RORγ(+) ILCs creates a unique microenvironment within mucosal draining lymph nodesEmma C Mackley, Stephanie Houston, Clare L Marriott, et al.
Journal of Hepatology|July 17, 2012
CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liverYe Htun Oo, Vanessa Banz, Dean Kavanagh, et al.
Cell|August 18, 2021
Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancerJeremy Goc, Mengze Lv, Nicholas J Bessman, et al.
Nature Medicine|February 16, 2016
Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cellsDavid R Withers, Matthew R Hepworth, Xinxin Wang, et al.
Nature Immunology|September 24, 2021
T-bet and RORα control lymph node formation by regulating embryonic innate lymphoid cell differentiationChristina Stehle, Timo Rückert, Rémi Fiancette, et al.
Mucosal Immunology|January 8, 2021
Intestinal-derived ILCs migrating in lymph increase IFNγ production in response to Salmonella Typhimurium infectionVerena Kästele, Johannes Mayer, Edward S Lee, et al.
Pageof 10